Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Endocrine Cancer · Brazil · 2025-07-23

Processing Time
265 days
Decision Date
2025-07-23
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in endocrine oncology, specifically focusing on the validation and clinical application of circulating tumor DNA (ctDNA) to detect molecular residual disease. Her work involves coordinating multi-institutional clinical trials and analyzing tumor genetic profiles to optimize treatment strategies for both malignant and benign adrenal lesions. The goal is to improve recurrence-free survival and therapeutic responses for cancer patients undergoing chemotherapy and immunotherapy.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research in ctDNA analysis intersects with core national objectives such as public health improvement and precision in therapeutic development.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 18 peer-reviewed articles, 281 citations, and role as a peer reviewer for leading journals demonstrate her standing as a trusted expert.

3 Waiver Benefit Met

The pioneering nature of the work in medical biotechnology and its potential to revolutionize cancer management makes it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 18 peer-reviewed journal articles, 20 conference abstracts, and 281 citations, with several papers ranking in the top 1% of her field. Her work was published in high-impact journals like Science Advances and The Lancet Oncology. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of her ctDNA research and her established expertise in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Government Alignment
Reference Letters Dependent

Similar Cases

Research Fellow

Biotechnology · Russia

WeGreened EB-2 (NIW) approved
Massachusetts 287 days 2025-02-10
The petitioner proposes to continue research in biomedical science with a focus on disease modeling, targeted therapy development, and the molecular characterization of rare tumors. The work involves genomic analysis of pediatric and adult tumors to enable personalized treatments and validate the effectiveness of drugs like seribantumab and zenocutuzumab. The intended impact is to address urgent gaps in oncology and overcome drug resistance mechanisms in under-researched cancers.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Brazil

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-23.

Browse all cases

At a Glance

Outcome approved
Processing 265 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Brazil All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist